PubMed Health⌕ Search

Biomedical subjects

G Batstone

Publications and source records attributed to G Batstone.

10 recordsLinked to original sources
PubMed2000

Educational supervision for PRHOs: getting it right?

The New Doctor highlights aspects of educational supervision for preregistration house officers that may serve as a lesson for improving the educational experience of all doctors in training. On the basis of research carried out in mid-Trent, this article highlights some of the issues relating to the training of educational supervisors and how these need to be put into context if further advances in education and training are to take place.

Consultants↗
PubMed1998

Supporting Pre-registration House Officers: the needs of educational supervisors of the first phase of postgraduate medical education.

The GMC's publications The New Doctor (GMC 1997) outlines an approach for the education of Pre-registration House Officers using designated educational supervisors. In order to establish appropriate means of training consultants to undertake this role, the Centre for Postgraduate and Continuing Medical Education at the Queens Medical Centre, Nottingham undertook a needs analysis. This consisted of a series of individual interviews with directors of postgraduate education in the mid-Trent region, four focus groups with consultants, and two dissemination workshops. The findings from the research have led to the development of a modular educational programme, based on the perceived needs and optimum structure indicated by the participants in the research process.

Consultants↗
PubMed1987

Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges.

Following a tolerance study, double-blind placebo controlled trials were conducted to determine the prophylactic effect of zinc gluconate lozenges on rhinovirus challenge and, in a third study, their therapeutic efficacy when given at the start of colds caused by virus inoculation was tested. In the prophylaxis study a total of 57 volunteers received lozenges of either zinc gluconate (23 mg) (29 volunteers) or matched placebo (28 volunteers) every 2 h while awake during a period of four and a half days. They were challenged with 10(2) tissue culture infecting dose (TCID50) of human rhinovirus 2 (HRV-2) on the second day of medication, and were monitored daily for symptoms and signs of colds and laboratory evidence of infection. Zinc reduced the total mean clinical score from 8.2 in the placebo group to 5.7 and the reduction of the mean clinical score was statistically significant on the second day after virus challenge. In the therapeutic study 69 volunteers were inoculated with 10(2) TCID50 of HRV-2 and those who developed cold symptoms were randomly allocated to receive either zinc gluconate lozenges (six volunteers) or matched placebo lozenges (six volunteers) every two hours they were awake for six days. Treatment of colds with zinc reduced the mean daily clinical score and this was statistically significant on the fourth and fifth day of medication. Similarly, medication also reduced the mean daily nasal secretion weight and total tissue count and these reductions were statistically significant on days two and six for nasal secretion weights and days four to six of medication for tissue counts when compared with placebo.(ABSTRACT TRUNCATED AT 250 WORDS)

Adult↗
PubMed1981

Urinary excretion patterns of cyclic AMP and cyclic GMP following thermal injury.

Measurement of 24-h urinary cyclic AMP and cyclic GMP levels in 19 patients for up to nine days after thermal injury has revealed differences in cyclic nucleotide excretion patterns between "severe" and "mild to moderate" groups of burned patients, classified according to a predictive index of burn mortality. Cyclic AMP excretion fell significantly from a high initial level in the "severe" group, but showed no significant change in the "mild to moderate" group. Differences in cyclic AMP excretion between the two groups of patients were only significant on the second day following burn injury. There was no correlation between cyclic AMP output averaged for each patient over the first nine days and percentage body surface area of the burn or the predictive index. In contrast to the results for cyclic AMP excretion, cyclic GMP output rose significantly over the 9-day period in severely burned patients, while levels reached a plateau on days four to six for the moderate to mild group. When cyclic GMP excretion was averaged over the first nine days for each patient, a significant correlation with both percent body surface area of burn and the predictive index of burn mortality was found. The tissue source or sources which are responsible for increased cyclic GMP excretion are as yet unknown.

Adolescent↗
PubMedDate not supplied

A-Z of management and finance in the NHS: outcomes and use of resources.

In general, clinical outcomes are the product of clinical practice and good outcomes are associated with the judicious application of the best available evidence of what constitutes good practice. From the patient's viewpoint this application needs to be tempered by personal choice, cultural beliefs, and questions of optimal time and location of treatment.

Comorbidity↗